Cargando…

A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity

BACKGROUND: Zika virus (ZIKV) and dengue virus (DENV) cause microcephaly and dengue hemorrhagic fever, respectively, leading to severe problems. No effective antiviral agents are approved against infections of these flaviviruses, calling for the need to develop potent therapeutics. We previously ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yaning, Tai, Wanbo, Wang, Xinyi, Jiang, Shibo, Debnath, Asim K., Du, Lanying, Chen, Shizhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202104/ https://www.ncbi.nlm.nih.gov/pubmed/35706035 http://dx.doi.org/10.1186/s12915-022-01344-w

Ejemplares similares

Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors
por: Gao, Yaning, et al.
Publicado: (2019)

Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
por: Tai, Wanbo, et al.
Publicado: (2018)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine
por: Wang, Xinyi, et al.
Publicado: (2019)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise
por: Tai, Wanbo, et al.
Publicado: (2019)

Gossypol Toxicity from Cottonseed Products
por: Gadelha, Ivana Cristina N., et al.
Publicado: (2014)

A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage
por: Gambino, Frank, et al.
Publicado: (2021)

Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection
por: Guo, Yan, et al.
Publicado: (2017)

Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy
por: Tai, Wanbo, et al.
Publicado: (2019)

Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4
por: Jiang, Shibo, et al.
Publicado: (2013)

A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC
por: Jiang, Shibo, et al.
Publicado: (2013)

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
por: Zeng, Lei-Ping, et al.
Publicado: (2017)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
por: Wu, Yanling, et al.
Publicado: (2017)

Advances in mRNA and other vaccines against MERS-CoV
por: Tai, Wanbo, et al.
Publicado: (2022)

Toxicity of Gossypol from Cottonseed Cake to Sheep Ovarian Follicles
por: Câmara, Antônio Carlos Lopes, et al.
Publicado: (2015)

The reversible effects of gossypol toxicity on male pigeons’ reproductive performance
por: Wannaratana, Suwarak, et al.
Publicado: (2022)

CD4(+) T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection
por: Wen, Jinsheng, et al.
Publicado: (2020)

Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket
por: Yu, Fei, et al.
Publicado: (2013)

Cytotoxicity of enantiomers of gossypol.
por: Joseph, A. E., et al.
Publicado: (1986)

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
por: Shi, Juan, et al.
Publicado: (2022)

Implication of vaccination against dengue for Zika outbreak
por: Tang, Biao, et al.
Publicado: (2016)

Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
por: Sootichote, Rochanawan, et al.
Publicado: (2023)

Development of Small-Molecule Inhibitors Against Zika Virus Infection
por: Wang, Lili, et al.
Publicado: (2019)

Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection
por: Khandia, Rekha, et al.
Publicado: (2018)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2023)

Cross-Protection of Dengue Virus Infection against Congenital Zika Syndrome, Northeastern Brazil
por: Pedroso, Celia, et al.
Publicado: (2019)

Searching for plant-derived antivirals against dengue virus and Zika virus
por: de Castro Barbosa, Emerson, et al.
Publicado: (2022)

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
por: Swanstrom, J. A., et al.
Publicado: (2016)

Characterization of gossypol biosynthetic pathway
por: Tian, Xiu, et al.
Publicado: (2018)

Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus
por: Baldwin, Whitney R., et al.
Publicado: (2021)

Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice
por: Liu, Zhicheng, et al.
Publicado: (2013)

Biodegradation of Gossypol by Aspergillus terreus-YJ01
por: Jiang, Yao, et al.
Publicado: (2023)

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Co-circulation of dengue, chikungunya, and Zika viruses and cross-protection
por: Joob, Beuy, et al.
Publicado: (2019)

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2016)

The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation
por: George, Parakkal Jovvian, et al.
Publicado: (2020)

Presence of free gossypol in whole cottonseed
por: Knutsen, Helle Katrine, et al.
Publicado: (2017)

Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
por: He, Lei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ctm6ehatlv8evkub9mrhl0i3qd